Clinical Study
The Risk of Endoscopic Mucosal Resection in the Setting of Clopidogrel Use
Table 1
Antiplatelet/anticoagulant use.
| | Antiplatelet/anticoagulant (APAC) | Total number of EMR performed | Frequency of GIB | Frequency of IE |
| | None | 922 | 10 | 1 | | Coumadin | 89 | 0 | 0 | | Clopidogrel | 17 | 0 | 1 | | Aspirin | 467 | 1 | 0 | | NSAID | 44 | 0 | 0 | | Coumadin and aspirin | 63 | 0 | 0 | | Aspirin and NSAID | 44 | 0 | 0 | | Coumadin, clopidogrel, and aspirin | 3 | 1 | 0 | | Clopidogrel and aspirin | 40 | 2 | 0 | | Coumadin and NSAID | 1 | 0 | 0 | | Coumadin and clopidogrel | 1 | 0 | 0 | | NSAID, clopidogrel, and aspirin | 5 | 0 | 0 | | Coumadin, aspirin, and NSAID | 2 | 0 | 0 | | Total | 1698 | 14 | 2 |
|
|
